New vaccine therapy to treat the deadly chemo-resistant ovarian cancer
Posted on April 13, 2012 by admin| Leave a comment
A better hope for thousands of women suffering from the ‘often resistant to chemotherapy’ ovarian cancer at its advanced stage. A new cancer vaccine therapy is on its way to launch expanding treatment options to such women. Thanks to the Cancer Treatment Centers of America. The vaccine is developed by AVAX Technologies, Inc. Dr. Edgar Staren, Chief Medical Officer of Cancer Treatment Centers of America said, Cancer Treatment Centers of America’s number one priority is to help our patients win the battle against cancer. This vaccine therapy represents a promising new chapter in the fight against this devastating disease and brings hope to women everywhere. Interestingly, this treatment method creates a patient-specific vaccine, using the patient’s own tumor tissues. The method also combines chemotherapy delivered directly into the abdominal cavity along with it. Dr. Staren said, To win the fight against cancer, it is absolutely vital we do everything we can to make innovative new treatments like this available to patients as soon as possible. It’s inconceivable that treatments like these – that give hope to patients – are often left on the laboratory bench, while cancer patients are told there is nothing more that can be done for them.
It is on the CTCA website.. that is why we see this being bought.. This is totally going back to 4 to 5 dollars.. and then maybe 50 to 60. It looks like a dream but it works and it is saving lives.. So do the math..
This is indeed encouraging, as it clearly states that the treatment is working. I think this could be huge especially when we see the MVAX come back to life with a new partner for OVAX and potential partial sale. WOW!!